Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
Analysts Are Bullish on These Healthcare Stocks: Monte Rosa Therapeutics (GLUE), Neurocrine (NBIX)
Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $35
Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Raises Target Price to $35
10 Small-cap U.S. Healthcare Stocks With the Strongest Momentum Grades
Wells Fargo Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $29
Kymera, Monte Rosa Among Gainers as Novartis Inks Deal for Molecular Glue Drugs